CD40-Mediated NF-κB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics. - Wikidata - wikimedia - TriplyDB

CD40-Mediated NF-κB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics.

CD40-Mediated NF-κB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics.

http://www.wikidata.org/entity/Q37645910

about

Role of Immunological Memory Cells as a Therapeutic Target in Multiple Sclerosis.The CD40-CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.

P2860

Q47130362-AD02C68C-DC52-462C-ACB7-95C355C1EB3B Q47221242-83FCB847-AF66-4C7C-9D1E-51EBB9945182

P2860

CD40-Mediated NF-κB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics.

http://www.wikidata.org/entity/Q37645910

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

CD40-Mediated NF-κB Activation ...... and Modulated by Therapeutics.

@en

CD40-Mediated NF-κB Activation ...... and Modulated by Therapeutics.

@nl

type

label

CD40-Mediated NF-κB Activation ...... and Modulated by Therapeutics.

@en

CD40-Mediated NF-κB Activation ...... and Modulated by Therapeutics.

@nl

prefLabel

CD40-Mediated NF-κB Activation ...... and Modulated by Therapeutics.

@en

CD40-Mediated NF-κB Activation ...... and Modulated by Therapeutics.

@nl

P1433

Q37645910-DA7275A7-7AF4-448F-A22A-32D7F66D97EF

P1476

Q37645910-998053BD-E48F-4969-84E6-61BBEC4553A2

P2093

Q37645910-08B7A6EB-760D-45FB-BC59-6D7EFD581713

Q37645910-133124F0-D5F6-4380-B24C-5EC799A26A51

Q37645910-B0FAED83-1D61-4496-96C5-A7D1E59C5F78

Q37645910-B1DDF85E-BE96-4041-BE0A-9AAD59B4F205

P2860

Q37645910-09613386-3318-4FDD-A97B-26FFAD1D2387

Q37645910-0E3C8F89-FFDA-4E44-8982-A44C3096F65A

Q37645910-1BD97592-1599-4E06-AEA8-FD425417627F

Q37645910-2891521C-0B23-4B3E-AA3E-9CE699C28788

Q37645910-397FA3A2-C88E-422F-997E-AC8FF4AE0CFA

Q37645910-4DD8F080-80FC-40E7-A7B0-E3C9EB82050A

Q37645910-55B42D9D-54A1-4DB4-8354-F2B5C5145744

Q37645910-5A366432-21B5-4B9A-845C-BFDEB04FAC64

Q37645910-60A13706-9BAF-462D-A68C-A41E7DDC5782

Q37645910-6108160F-94D2-452C-A4BC-152E6AD95A72

P304

Q37645910-0B7273D1-2C55-456A-BFB6-0C2D312202CB

P31

Q37645910-50962048-1166-4F8A-A562-F57571657454

P356

Q37645910-E53E6E5E-3E6F-4CFE-A558-9039EE81FFE6

P407

Q37645910-6B86D9B6-F4A4-4104-8628-2314036D96B3

P433

Q37645910-F4722D36-15BC-44D3-9761-05C5E0959325

P478

Q37645910-756C4893-3B8F-4F3E-9652-8F3A6D5E3DA3

P50

Q37645910-268DEEAD-D366-4724-84D7-BB21AA449DFB

Q37645910-4106091E-5534-4994-A7FA-5DEDAF95BC59

Q37645910-CF709C96-8293-4E56-91E7-95A048965079

Q37645910-E586F97B-BC14-4FA2-986E-BD2317DCE257

P577

Q37645910-799B2EF1-EF9A-4F0C-8205-0104AE83C8D9

P698

Q37645910-D3ABAE69-CB14-4B14-B327-19DE71F18B8C

P921

Q37645910-CE6EA328-5091-4FEB-9DD1-DB4F937DDF92

Q37645910-E1695E1A-07A2-40DD-A7C7-A78BFF167E06

P932

Q37645910-F3E8ECEA-FFF3-430B-B947-F6EE946CAE76

P356

JIMMUNOL.1600782

P1433

Journal of Immunology

P1476

CD40-Mediated NF-κB Activation ...... and Modulated by Therapeutics.

@en

P2093

Ding Chen

http://www.w3.org/2001/XMLSchema#string

Elliot M Frohman

http://www.w3.org/2001/XMLSchema#string

Michael K Racke

http://www.w3.org/2001/XMLSchema#string

Nancy L Monson

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

The TRAF6-NF kappa B signaling pathway in autoimmunity: not just inflammation.

B cells from relapsing remitting multiple sclerosis patients support neuro-antigen-specific Th17 responses

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.

Progress towards the development of anti-inflammatory inhibitors of IKKbeta.

The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability

Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes.

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.

Signaling by CD40 and its mimics in B cell activation.

Aberrant CD40-induced NF-κB activation in human lupus B lymphocytes

P304

4257-4265

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1600782

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

197

http://www.w3.org/2001/XMLSchema#string

P50

Enrique Alvarez

Benjamin M. Greenberg

P577

2016-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27798157

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

5312703

http://www.w3.org/2001/XMLSchema#string